Wall Street Icon: “You must get on the right side of this thing”

I created one of the first quantitative analysis-based stock picking systems long before "quants" became a thing on Wall Street… leading Forbes to call me "King of the Quants." I'm writing to you today because my system has recently uncovered a market phenomenon I haven't seen in 30 years.

This market shakeup is going to be much more intense.

QURE Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 4.74%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $421,017.91

uniQure Insider Trading History Chart

uniQure Share Price & Price History

^$16.98

▲ +1.51 (9.76%)

As of 12/20/2024 06:31 PM ET

Days: 30 | 90 | 365

The #1 Coin for November 2024

From Crypto 101 Media | Ad

Grayscale Investments just announced a new fund offering access to a HOT new DeFi coin… And thanks to this newly established trust, I believe this coin could skyrocket up to 150x+ in the next 30 days alone! I've compiled everything you need to know about this once-in-a-lifetime DeFi project into a brand-new comprehensive guide…

You can get access to the report by clicking here now…

uniQure Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
12/9/2024	Christian Klemt	CFO	Sell	1,796	$7.55	$13,559.80	166,713
12/9/2024	Matthew C. Kapusta	CEO	Sell	3,418	$7.63	$26,079.34	597,915
6/26/2024	Walid Abi-Saab	Insider	Sell	1,447	$4.36	$6,308.92	115,253
6/13/2024	Jeannette Potts	Insider	Sell	4,781	$4.98	$23,809.38	91,819
6/13/2024	Rachelle Suzanne Jacques	Director	Sell	2,221	$5.14	$11,415.94	14,408
2/26/2024	Christian Klemt	CFO	Sell	15,906	$6.38	$101,480.28	116,948
2/26/2024	Matthew C. Kapusta	CEO	Sell	27,904	$6.35	$177,190.40	440,839
2/26/2024	Pierre Caloz	COO	Sell	9,455	$6.47	$61,173.85	85,643
9/18/2023	Ricardo Dolmetsch	Insider	Sell	5,841	$7.46	$43,573.86	163,404
7/10/2023	Pierre Caloz	COO	Sell	15,117	$11.36	$171,729.12	95,098
6/16/2023	Christian Klemt	CFO	Sell	1,587	$18.94	$30,057.78	132,854
6/16/2023	Pierre Caloz	COO	Sell	2,920	$18.80	$54,896.00	110,215
6/16/2023	Rachelle Suzanne Jacques	Director	Sell	2,301	$18.76	$43,166.76	16,629
3/7/2023	Alexander Edward Kuta, III	VP	Sell	585	$21.36	$12,495.60	90,381
3/7/2023	Christian Klemt	CFO	Sell	986	$21.36	$21,060.96	134,441
3/7/2023	Matthew C. Kapusta	CEO	Sell	2,521	$21.39	$53,924.19	468,743
3/7/2023	Pierre Caloz	COO	Sell	990	$21.33	$21,116.70	113,135
3/7/2023	Ricardo Dolmetsch	Insider	Sell	837	$21.04	$17,610.48	169,245
1/18/2023	Paula Soteropoulos	Director	Sell	6,000	$22.59	$135,540.00	16,382
12/13/2022	Paula Soteropoulos	Director	Sell	3,000	$23.45	$70,350.00	16,382
12/9/2022	Alexander Edward Kuta, III	VP	Sell	2,338	$22.34	$52,230.92	95,652
12/9/2022	Christian Klemt	CFO	Sell	2,608	$22.35	$58,288.80	107,180
12/9/2022	Matthew C. Kapusta	CEO	Sell	6,648	$22.44	$149,181.12	368,481
12/9/2022	Pierre Caloz	COO	Sell	2,941	$22.22	$65,349.02	68,870
12/9/2022	Ricardo Dolmetsch	Insider	Sell	2,219	$22.30	$49,483.70	127,406
11/29/2022	Paula Soteropoulos	Director	Sell	6,200	$25.38	$157,356.00	16,382
9/21/2022	Alexander Edward Kuta, III	VP	Sell	2,306	$18.65	$43,006.90	92,890
7/28/2022	Alexander Edward Kuta, III	VP	Sell	27,358	$25.00	$683,950.00	95,196
7/22/2022	Alexander Edward Kuta, III	VP	Sell	5,643	$25.00	$141,075.00	95,196
6/16/2022	Christian Klemt	CFO	Sell	1,687	$13.20	$22,268.40	104,688
6/16/2022	Pierre Caloz	COO	Sell	7,575	$13.21	$100,065.75	64,511
2/28/2022	Alexander Edward Kuta, III	VP	Sell	3,405	$16.72	$56,931.60
2/28/2022	Christian Klemt	CFO	Sell	4,075	$16.80	$68,460.00
2/28/2022	Leonard E Post	Director	Sell	795	$16.64	$13,228.80
2/28/2022	Matthew C. Kapusta	CEO	Sell	10,195	$16.70	$170,256.50
2/28/2022	Ricardo Dolmetsch	Insider	Sell	1,484	$16.68	$24,753.12
1/26/2022	Alexander Edward Kuta, III	VP	Sell	2,945	$18.02	$53,068.90
1/26/2022	Christian Klemt	CFO	Sell	3,963	$18.03	$71,452.89
1/26/2022	Matthew C. Kapusta	CEO	Sell	10,901	$18.10	$197,308.10
1/26/2022	Robert Gut	Director	Sell	2,348	$18.12	$42,545.76

This Crypto Is Set to Explode in December

From Crypto 101 Media | Ad

It's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this surge is a massive new blockchain development…

YES, I WANT THE #1 CRYPTO NOW

SEC Filings (Institutional Ownership Changes) for uniQure (NASDAQ:QURE)

78.83% of uniQure stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

uniQure Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
11/27/2024	Franklin Resources Inc.	1,492,962	$7.36M	0.0%	N/A	3.063%
11/16/2024	Geode Capital Management LLC	508,602	$2.51M	0.0%	+1.3%	1.044%
11/15/2024	Y Intercept Hong Kong Ltd	57,333	$0.28M	0.0%	N/A	0.118%
11/15/2024	Stifel Financial Corp	60,996	$0.30M	0.0%	-3.2%	0.125%
11/15/2024	Quarry LP	11,699	$58K	0.0%	N/A	0.024%
11/15/2024	RTW Investments LP	10,000	$49K	0.0%	N/A	0.021%
11/15/2024	Point72 Asset Management L.P.	976,893	$4.82M	0.0%	+336.1%	2.004%
11/14/2024	PFM Health Sciences LP	121,628	$0.60M	0.0%	-55.7%	0.250%
11/14/2024	PDT Partners LLC	57,199	$0.28M	0.0%	-58.8%	0.117%
11/14/2024	Verition Fund Management LLC	114,767	$0.57M	0.0%	-77.9%	0.235%
11/14/2024	Walleye Capital LLC	90,142	$0.44M	0.0%	N/A	0.185%
11/14/2024	PEAK6 Investments LLC	52,752	$0.26M	0.0%	N/A	0.108%
11/13/2024	BNP Paribas Financial Markets	427,191	$2.11M	0.0%	-28.7%	0.876%
11/13/2024	FMR LLC	350,572	$1.73M	0.0%	+8,056.6%	0.719%
11/13/2024	Dynamic Technology Lab Private Ltd	12,943	$64K	0.0%	-27.7%	0.027%
11/12/2024	Charles Schwab Investment Management Inc.	277,275	$1.37M	0.0%	+6.3%	0.569%
11/8/2024	Connor Clark & Lunn Investment Management Ltd.	14,050	$69K	0.0%	N/A	0.029%
11/4/2024	Sigma Planning Corp	48,245	$0.24M	0.0%	-51.6%	0.099%
11/2/2024	Privium Fund Management B.V.	744,916	$3.67M	0.9%	+16.3%	1.530%
11/1/2024	Atria Investments Inc	10,844	$53K	0.0%	N/A	0.022%
10/25/2024	China Universal Asset Management Co. Ltd.	10,093	$50K	0.0%	+57.0%	0.021%
10/25/2024	abrdn plc	1,929,061	$9.51M	0.0%	+381.7%	3.961%
10/24/2024	Clear Harbor Asset Management LLC	19,500	$96K	0.0%	-59.4%	0.040%
10/23/2024	Ballentine Partners LLC	23,534	$0.12M	0.0%	N/A	0.048%
10/23/2024	Assenagon Asset Management S.A.	271,346	$1.34M	0.0%	+49.1%	0.557%
9/16/2024	Cubist Systematic Strategies LLC	25,494	$0.11M	0.0%	+130.9%	0.052%
8/19/2024	Point72 Asset Management L.P.	224,004	$1M	0.0%	-2.7%	0.460%
8/16/2024	Doheny Asset Management CA	27,080	$1.22M	0.7%	N/A	0.056%
8/16/2024	Algert Global LLC	39,281	$0.18M	0.0%	N/A	0.081%
8/14/2024	Cubist Systematic Strategies LLC	25,494	$0.11M	0.0%	+130.9%	0.052%
8/14/2024	Marshall Wace LLP	39,078	$0.18M	0.0%	N/A	0.080%
8/12/2024	Vanguard Personalized Indexing Management LLC	13,301	$59K	0.0%	+21.0%	0.027%
8/9/2024	Total Clarity Wealth Management Inc.	16,450	$74K	0.0%	N/A	0.034%
8/8/2024	American Century Companies Inc.	67,699	$0.30M	0.0%	+14.6%	0.139%
8/7/2024	Doheny Asset Management CA	27,080	$1.22M	0.9%	N/A	0.056%
8/6/2024	Acadian Asset Management LLC	513,746	$2.30M	0.0%	-16.3%	1.058%
8/1/2024	Privium Fund Management B.V.	640,416	$2.87M	0.8%	+10.6%	1.319%
7/18/2024	Assenagon Asset Management S.A.	181,946	$0.82M	0.0%	N/A	0.375%
7/17/2024	Clear Harbor Asset Management LLC	48,000	$0.22M	0.0%	+35.2%	0.099%
7/12/2024	SG Americas Securities LLC	17,587	$79K	0.0%	N/A	0.036%
5/17/2024	Ikarian Capital LLC	469,133	$2.44M	0.3%	+198.1%	0.966%
5/14/2024	Carlson Capital L P	227,400	$1.18M	0.1%	+16.6%	0.468%
5/11/2024	Covestor Ltd	53,690	$0.28M	0.2%	+103.2%	0.111%
5/10/2024	Acadian Asset Management LLC	613,490	$3.19M	0.0%	+133.1%	1.282%
5/10/2024	Vanguard Group Inc.	1,072,536	$5.58M	0.0%	+11.4%	2.242%
5/1/2024	BNP Paribas Financial Markets	736,724	$3.83M	0.0%	+4.3%	1.540%
5/1/2024	Mirae Asset Global Investments Co. Ltd.	157,312	$0.82M	0.0%	+74.1%	0.329%
4/30/2024	Privium Fund Management B.V.	578,915	$3.01M	0.8%	+30.3%	1.210%
4/29/2024	China Universal Asset Management Co. Ltd.	9,922	$52K	0.0%	+58.5%	0.020%
2/26/2024	Virtu Financial LLC	28,779	$0.20M	0.0%	N/A	0.060%
2/15/2024	Bridger Management LLC	362,349	$2.45M	0.9%	+2,917.3%	0.757%
2/14/2024	Pennant Investors LP	48,500	$0.33M	0.1%	N/A	0.101%
2/14/2024	Pale Fire Capital SE	65,600	$0.44M	0.1%	+9.2%	0.137%
2/14/2024	Vestal Point Capital LP	3,925,000	$26.57M	2.8%	N/A	8.210%
2/14/2024	Sectoral Asset Management Inc.	292,592	$1.98M	0.9%	N/A	0.612%
2/13/2024	Rafferty Asset Management LLC	368,783	$2.50M	0.0%	-5.6%	0.771%
2/8/2024	Vanguard Personalized Indexing Management LLC	12,659	$86K	0.0%	N/A	0.026%
2/7/2024	Jump Financial LLC	108,882	$0.74M	0.0%	-11.2%	0.228%
2/7/2024	BNP Paribas Financial Markets	706,670	$4.78M	0.0%	+173.5%	1.478%
2/1/2024	Sigma Planning Corp	28,745	$0.20M	0.0%	-51.5%	0.060%
1/31/2024	abrdn plc	400,480	$2.71M	0.0%	N/A	0.838%
1/30/2024	Zurcher Kantonalbank Zurich Cantonalbank	4,088	$28K	0.0%	-69.5%	0.009%
1/30/2024	Vontobel Holding Ltd.	295,042	$2M	0.0%	+458.5%	0.617%
1/24/2024	Mirae Asset Global Investments Co. Ltd.	90,354	$0.61M	0.0%	-57.9%	0.189%
1/24/2024	China Universal Asset Management Co. Ltd.	6,258	$42K	0.0%	+222.1%	0.013%
1/16/2024	Raymond James & Associates	52,224	$0.35M	0.0%	+6.4%	0.109%
1/12/2024	SG Americas Securities LLC	17,159	$0.12M	0.0%	N/A	0.036%
1/11/2024	Sanders Morris Harris LLC	68,070	$0.46M	0.2%	-81.5%	0.142%
1/8/2024	Harbor Capital Advisors Inc.	30,883	$0.21M	0.0%	+21.1%	0.065%
12/13/2023	Teachers Retirement System of The State of Kentucky	9,001	$61K	0.0%	-33.6%	0.019%
12/7/2023	Hudson Bay Capital Management LP	390,200	$2.62M	0.0%	+66.0%	0.816%
12/6/2023	Citigroup Inc.	766,521	$5.14M	0.0%	+667.9%	1.603%
11/27/2023	Banque Pictet & Cie SA	160,629	$1.08M	0.0%	-4.4%	0.336%
11/15/2023	Laurion Capital Management LP	10,844	$73K	0.0%	N/A	0.023%
11/14/2023	683 Capital Management LLC	1,575,000	$10.57M	0.8%	+21.6%	3.294%
11/14/2023	Schonfeld Strategic Advisors LLC	382,629	$2.57M	0.0%	-10.7%	0.800%
11/14/2023	Nomura Holdings Inc.	10,000	$67K	0.0%	N/A	0.021%
11/14/2023	Profund Advisors LLC	64,172	$0.43M	0.0%	+74.3%	0.134%
11/13/2023	Covestor Ltd	34,737	$0.23M	0.2%	+364.8%	0.073%
11/13/2023	Algert Global LLC	414,241	$2.78M	0.1%	+237.6%	0.866%
11/13/2023	Regal Investment Advisors LLC	13,967	$94K	0.0%	N/A	0.029%
11/13/2023	Rafferty Asset Management LLC	390,844	$2.62M	0.0%	+97.3%	0.817%
11/13/2023	E Fund Management Co. Ltd.	20,075	$0.14M	0.0%	+88.4%	0.042%
11/9/2023	Citigroup Inc.	766,521	$5.14M	0.0%	+667.9%	1.604%
11/9/2023	Headlands Technologies LLC	4,648	$31K	0.0%	N/A	0.010%
11/8/2023	Swiss National Bank	99,400	$0.67M	0.0%	+8.0%	0.208%
11/7/2023	Quantbot Technologies LP	24,600	$0.17M	0.0%	+1,194.7%	0.051%
11/7/2023	Alpha DNA Investment Management LLC	79,611	$0.53M	0.2%	+26.7%	0.167%
11/7/2023	Barclays PLC	989,562	$6.64M	0.0%	+527.8%	2.070%
11/7/2023	Fox Run Management L.L.C.	16,153	$0.11M	0.0%	N/A	0.034%
11/7/2023	Jump Financial LLC	122,618	$0.82M	0.0%	N/A	0.257%
11/6/2023	Sigma Planning Corp	59,255	$0.40M	0.0%	+18.8%	0.124%
11/6/2023	Privium Fund Management B.V.	281,606	$1.89M	0.6%	+6.5%	0.589%
11/2/2023	Diamond Hill Capital Management Inc.	24,908	$0.17M	0.0%	N/A	0.052%
11/2/2023	Banque Pictet & Cie SA	160,629	$1.08M	0.0%	-4.4%	0.336%
10/31/2023	CTC Alternative Strategies Ltd.	13,000	$87K	0.2%	N/A	0.027%
10/26/2023	Mirae Asset Global Investments Co. Ltd.	214,686	$1.44M	0.0%	+12.6%	0.449%
10/25/2023	BluePath Capital Management LLC	3,988	$27K	0.0%	N/A	0.008%
10/24/2023	Bank of New York Mellon Corp	49,745	$0.33M	0.0%	-77.9%	0.104%
10/24/2023	Raymond James & Associates	49,079	$0.33M	0.0%	+220.1%	0.103%

Data available starting January 2016

uniQure N.V. develops treatments for patients suffering from rare and other devastating diseases. It offers HEMGENIX that has completed Phase III HOPE-B pivotal trial for the treatment of hemophilia B. The company also develops AMT-130, a gene therapy that is in Phase I/II clinical study for the treatment of Huntington's disease. In addition, it is developing AMT-162, which is in preclinical trial for the treatment of superoxide dismutase 1- amyotrophic lateral sclerosis; AMT-260 that is in preclinical trial to treat temporal lobe epilepsy; AMT-191, which is in preclinical trial for the treatment of fabry disease; AMT-161 that is in preclinical trial to treat amyotrophic lateral sclerosis caused by mutations; AMT-240, which is in preclinical trial to for the treatment of autosomal dominant Alzheimer's disease; and AMT-210 that is in preclinical trial to treat Parkinson's disease. The company was founded in 1998 and is headquartered in Amsterdam, the Netherlands.

Today's Range

Now: $16.98

$15.35

$17.58

50 Day Range

MA: $8.13

$5.56

$17.40

52 Week Range

Now: $16.98

$3.73

$17.71

Volume

2,053,596 shs

Average Volume

1,659,723 shs

Market Capitalization

$827.66 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.89

Who are the company insiders with the largest holdings of uniQure?: uniQure's top insider shareholders include:
Matthew C Kapusta (CEO)
Ricardo Dolmetsch (Insider)
Christian Klemt (CFO)
Walid Abi-Saab (Insider)
Pierre Caloz (COO)
Jeannette Potts (Insider)
Alexander Edward Kuta III (VP)
Rachelle Suzanne Jacques (Director)
Paula Soteropoulos (Director)
Learn More about top insider investors at uniQure.
Who are the major institutional investors of uniQure?: uniQure's top institutional investors include:
abrdn plc — 3.96%
Franklin Resources Inc. — 3.06%
Point72 Asset Management L.P. — 2.00%
Privium Fund Management B.V. — 1.53%
Geode Capital Management LLC — 1.04%
BNP Paribas Financial Markets — 0.88%
Learn More about top institutional investors of uniQure stock.
Which institutional investors are selling uniQure stock?: In the last quarter, QURE stock was sold by these institutional investors:
Verition Fund Management LLC
BNP Paribas Financial Markets
PFM Health Sciences LP
PDT Partners LLC
Sigma Planning Corp
Clear Harbor Asset Management LLC
Dynamic Technology Lab Private Ltd
Stifel Financial Corp
In the last year, company insiders that have sold uniQure company stock include:
Matthew C Kapusta (CEO)
Ricardo Dolmetsch (Insider)
Christian Klemt (CFO)
Walid Abi-Saab (Insider)
Pierre Caloz (COO)
Jeannette Potts (Insider)
Learn More investors selling uniQure stock.
Which institutional investors are buying uniQure stock?: Within the previous quarter, QURE stock was acquired by institutional investors including:
abrdn plc
Franklin Resources Inc.
Point72 Asset Management L.P.
FMR LLC
Privium Fund Management B.V.
Walleye Capital LLC
Assenagon Asset Management S.A.
Y Intercept Hong Kong Ltd